Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the H2431 Covid Vaccine Mandates topic
No spam. Unsubscribe anytime.
Advocates for 'no COVID mandate' bill urge protections; state health experts warn of public-health tradeoffs
Summary
Supporters of H2431, which would bar requiring COVID-19, mRNA or 'gene-altering' vaccines for entry or services, told the Joint Committee on Public Health the bill would protect religious freedom and bodily autonomy; public-health clinicians and researchers pushed back, saying existing law and emergency authority require careful calibration.
Representative Gaski and multiple parents and advocacy groups testified on H2431, "An act prohibiting the requirement of a COVID‑19 vaccine, mRNA vaccine or gene altering therapy," a measure aimed at preventing employers, schools and public accommodations from conditioning access on such vaccines.
Supporters described personal and economic harms from pandemic-era mandates and framed the legislation as a safeguard against future coercion. Julie Boris of Health Rights Massachusetts testified she supported H2431 to ensure that, "the injustices of the COVID era can never happen again," and said many people reported job loss and alleged vaccine injuries in testimony she collected. Rep. Gaski said the bill would protect privacy and religious conscience and prevent future mandates requiring disclosure of vaccination status.
Opponents including clinicians and public-health groups said the bill would be overly broad and could limit legitimate public-health tools during outbreaks and in medical-clinical settings. They noted that existing law provides emergency authorities and that targeted protections for workers or settings would require careful drafting. Funeral directors (supporting a different bill, H2463) and other groups asked the committee to balance worker protections with occupational health requirements.
Lawmakers asked clarifying questions about where the bill would apply (clinical settings, educational clinical rotations) and whether its language would interfere with existing medical education or hospital credentialing requirements. Supporters of the bill said H2431 would not change insurers' payment rules but objectors pressed for precise definitions of "gene-altering" therapies and asked drafters to state whether the law would apply to all future platforms or only the COVID products in question.
The committee did not take a vote; members requested clearer definitions and scope if sponsors want the committee to advance the bill.
